Trade Summary

2 days ago, Looker Benjamin, serving as Chief Legal Officer at Esperion Therapeutics, Inc. (ESPR), sold 11,824 shares at $3.16 per share, for a total transaction value of $37,304.72. Following this transaction, Looker Benjamin now holds 667,524 shares of ESPR.

This sale represents a 1.74% decrease in Looker Benjamin's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:06 PM ET, 1 day after the trade was made.

Esperion Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.